Immediate Impact

53 standout
Sub-graph 1 of 25

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
2 intermediate papers

Works of Hanze Zhang being referenced

PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation
2015

Author Peers

Author Last Decade Papers Cites
Hanze Zhang 242 183 157 161 27 736
Sundeep Agrawal 314 219 78 161 32 619
Giovanni M. Bariani 208 414 110 185 32 775
Feng Wen 124 215 124 200 52 681
Sarah Bray 301 307 273 78 28 846
Masoud Babaei 257 373 117 210 21 748
Serafina Mammoliti 152 431 90 141 47 814
Mivael Olivera 215 432 82 134 29 766
Fadi Farhat 134 194 184 231 55 669
Chana Weinstock 127 533 122 282 42 793
Yanhong Zhou 103 180 75 184 22 731

All Works

Loading papers...

Rankless by CCL
2026